Clinical Trial Update: Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass [NA]

View source ↗

Summary

This entry notes an ongoing safety study of an acellular tissue-engineered vascular graft for coronary artery bypass grafting, sponsored by Vascudyne, Inc., wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Multivessel Coronary Artery Disease

Drugs mentioned

• Acellular Tissue Engineered Vessel

Snippet

Sponsor: Vascudyne, Inc. | Conditions: Coronary Artery Disease, Multi Vessel Coronary Artery Disease | NA | Status: ENROLLING_BY_INVITATION